Richard W. Scott
Technik-/Wissenschafts-/F&E-Leiter bei PolyMedix Pharmaceuticals, Inc.
Profil
Mr. Richard Scott joined Smith New Court in the City of London as a graduate trainee, prior to moving to Hambros Bank, where he was the Investment Strategist, specialising in US equities and global funds.
He moved down to the West Country to join Exeter Investment Group in 1995, and was in charge of the firm’s conventional investment trust holdings.
He was the manager of The New Zealand Investment Trust, and won many awards for his management of two funds, Exeter Pacific Growth and Exeter Global Opportunities.
He continued with the firm through a period of major corporate change involving deals with iimia, Miton and Midas, and managed iimia Growth & Income Fund from its launch in January 2005 through to his resignation in June 2008 to take up the position of Chief Investment Officer at Hawksmoor Investment Management.
He was Citywire rated for his management of the Exeter and iimia funds, and was the Citiwire Fund Manager of the year in 2002 in both the Global and International categories.
He is an Associate of the UK Society of Investment Professionals.
He is a History graduate from Exeter University with a History degree in 1987.
Aktive Positionen von Richard W. Scott
Unternehmen | Position | Beginn |
---|---|---|
PolyMedix Pharmaceuticals, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2002 |
Ehemalige bekannte Positionen von Richard W. Scott
Unternehmen | Position | Ende |
---|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01.01.2001 |
POLYMEDIX, INC. | Gründer | - |
Ausbildung von Richard W. Scott
University of Pennsylvania | Doctorate Degree |
Muhlenberg College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
PolyMedix, Inc.
PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology PolyMedix, Inc. engaged in developing first-in-class, small-molecule defensin-mimetics for the treatment of serious acute care conditions. The company was founded in 2002 and was headquartered in Radnor, PA. | Health Technology |
PolyMedix Pharmaceuticals, Inc. | |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |